If You Want to Stent … Do Intravascular Ultrasound!⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.  by Hodgson, John McB.
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f You Want to Stent . . .
o Intravascular Ultrasound!*
ohn McB. Hodgson, MD
ilkes-Barre, Pennsylvania
ost invasive cardiologists are familiar with the common
atheterization lab “joke” that if you want to justify placing
stent, use intravascular ultrasound (IVUS) to assess the
esion and that if you prefer medical therapy, use fractional
ow reserve (FFR) to assess the lesion. Nam et al. (1) has
icely provided a study that documents the validity of this
tatement. In their retrospective study involving the use of
ither FFR or IVUS for intermediate lesion assessment, the
ate of stenting was 3 times higher in the IVUS assessed
See page 812
roup. This result is expected based on our understanding of
uid dynamics and coronary lesions. I will address that
urther. The most important finding of this study, however,
s that once again, physiologically (FFR)-guided decisions
egarding percutaneous coronary intervention (PCI) are safe
nd yield excellent patient outcomes. After all, ensuring
xcellent patient outcome with appropriate resource utiliza-
ion (i.e., cost-effectiveness) is our prime responsibility.
Little Physics (Sorry)
he nature of flow through tubes of various sizes has been
ell understood for hundreds of years. In the 18th century,
Dutch-born mathematician and physicist Daniel Bernoulli
1700 to 1782) (Fig. 1) discovered the principle that bears
is name while conducting experiments concerning the
onservation of energy. In 1738, he published his observa-
ions in the book Hydrodynamic (2) (Fig. 2). The principle
e described relevant to stenotic fluid-carrying tubes is
ummarized (and very much simplified) in the following
quation:
P 1/AS  l  V2,
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ennsylvania. Dr. Hodgson has received speaker fees ($10,000) from Volcano and
ducational grants ($10,000) from Volcano and RADI (St. Jude) Medical.here P is the pressure drop across a stenosis, As is the
inimal cross sectional area inside the stenosis, l is length,
nd V is blood flow velocity through the tube.
Thus, longer lesions, tighter lesions, and conditions of
igh flow will lead to greater pressure (energy) loss across a
tenosis. Fractional flow reserve accurately determines this
ressure loss and is well validated as a method able to
redict myocardial ischemia. On the other hand, IVUS
easures only 1 component of the Bernoulli relationship:
s.. Therefore, it should be no surprise that IVUS is less
ell suited to assessing the physiologic significance of a
iven stenosis. Further, IVUS cannot account for another
mportant physical factor: the blood flow requirements of
he subtended myocardial perfusion bed. Fractional flow
eserve is not only lesion-specific, but also accounts for the
ariable myocardial blood flow requirements and resulting
mpact of an upstream stenosis on this specific myocardial
ed. For example, a 70% stenosis in a vessel subtending a
mall diagonal or a previously infracted mid-anterior de-
cending territory will have less physiologic impact than an
dentical lesion in a mid-anterior descending subtending a
ealthy territory. Because the latter myocardium requires
igher flow (and P is exponentially related to flow), the
FR will be lower, even though the lesion is identical. This
isparity has been described in 3 studies (3–5) detailing the
oor relationship between FFR and IVUS minimal lesion
rea even in the best-case scenario of single-vessel, single-
Figure 1. Sketch of Daniel Bernoulli
Daniel Bernoulli was born February 8, 1700, Groningen, the Netherlands,
and died March 17, 1782, Basel, Switzerland.
l
t
p
l
b
u
t
F
b
r
a
c
4
a
P
a
d
n
a
s
l
s
l
i
a
p
C
T
g
t
d
f
t
b
•
•
•
m
b
h
p
c
r
u
R
D
M
m
R
1
2
3
4
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 3 , N O . 8 , 2 0 1 0 Hodgson
A U G U S T 2 0 1 0 : 8 1 8 – 2 0 Editorial Comment
819esion stenosis (r2 between 0.4 and 0.6). Although it is
echnically possible to measure all of the necessary physical
roperties of a stenosis with IVUS and calculate the pressure
oss and FFR, this is not clinically practical (6). Thus, it has
een clear for nearly 300 years that the best way to
nderstand the physical limitation imposed by a stenosis is
o measure the pressure loss across it during flow, that is,
FR.
Unfortunately, many of us have forgotten even the most
asic of physics: the area of a circle (r2). Understanding the
elationship between vessel diameter and its cross-sectional
rea is critical to proper interpretation of IVUS in the
atheterization lab. The area of a healthy 2.5-mm vessel is
.9 mm2. Thus, the finding of a lesion with cross-sectional
rea of 4 mm2 in this vessel should not prompt concern (or
CI). This lesion is only a 28% area stenosis! It is well
ccepted that “significant” coronary lesions must be 50%
iameter stenosis (equivalent to approximately 75% area ste-
osed). Similarly, a 3.0-mm vessel has an area of 7.1 mm2, so
lesion with minimal area of 4.0 mm2 yields only a 44% area
tenosis. It should be obvious that a single IVUS minimal
esion area cannot be applied to all size vessels to determine
ignificance. Alternatively, it is true that deferring PCI in a
Figure 2. Faceplate From Hydrodynamic
Faceplate from Daniel Bernoulli’s book Hydrodynamic.esion with an IVUS-defined minimal area greater than 4 mm2s associated with excellent clinical outcome (7). In the future,
pplication of IVUS-based lesion compositional analysis may
rovide additional differentiating information.
linical Application
he clinical uses of both IVUS and FFR have been steadily
rowing, with acceleration in recent years due to multiple
rial publications showing utility for lesion evaluation, PCI
eferral, and PCI guidance. The study by Nam et al. (1)
urther assists us in understanding how to incorporate these
ools into every day practice. Based on existing data, I
elieve rational integration would include:
Routine use of FFR for intermediate lesions (40% to 70%
visual stenosis) to determine if PCI is needed (i.e., use
physiology tools to determine physiology). There should
be no concern for adverse long-term patient outcome for
those in whom PCI is deferred.
Use of IVUS for lesion definition and PCI guidance in
patients for whom the need for PCI is clear (i.e., use
anatomic tools to guide anatomic processes).
In cases where FFR documents the need for PCI, IVUS
can be used for PCI guidance.
A recent review by Magni et al. (8) highlights the comple-
entary nature of IVUS and FFR. The era of “competition”
etween physiology and anatomy must end. At Geisinger, we
ave incorporated both FFR and IVUS into our ProvenCare
rocess for ensuring optimal PCI. In this process, where the
ost is fixed and the procedure comes with a “warranty,” we
equire that every aspect of the procedure is evidence-based and
niformly applied (9).
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